Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × repotrectinib × Clear all

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 361 Radiotherapy 234 fludarabine 205 Gemcitabine 180 Cisplatin 175 pembrolizumab 159 Nivolumab 158 Paclitaxel 154 Carboplatin 141 Magnetic Resonance Spectroscopy 138 fludarabine phosphate 134 Bevacizumab 112 Temozolomide 109 Irinotecan 109 Cytarabine 108 Specimen Handling 104 Capecitabine 104 Radiosurgery 103 Radiation 100 Docetaxel 100 Biopsy 94 Etoposide 93 Dexamethasone 92 Ipilimumab 91 Rituximab 90 Fluorouracil 89 Oxaliplatin 88 Filgrastim 86 Sorafenib 85 Lenalidomide 82

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04772235 2024-04-03

TOTEM

Instituto Oncológico Dr Rosell

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡